Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing
The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.
The guideline, PD-L1 Testing of Patients With Lung Cancer for Immunooncology Therapies, includes a draft summary of six recommendations, which is now available for an open comment period from March 31 to April 23, 2021.
All stakeholders-;including pathologists, oncologists, hospital or laboratory managers, and patient advocacy group representatives-;are encouraged to review and submit feedback on these draft recommendations.
Baptist Health Floyd names chief medical officer - Louisville Business First
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Biocept Reports 2020 Fourth Quarter and Full Year Financial Results
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Everlywell Appoints Former U S Surgeon General Regina Benjamin, MD to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
At-Home COVID-19 Testing: Convenience, Cost, Caveats
Experts agree that COVID-19 testing has had its challenges and has evolved over the past year. It s a very, very significant day, Kisha Mitchell Richards, MD, director of pathology and laboratory at Greenwich Hospital, in Greenwich, CT, said during a March 11 webinar on COVID-19. The webinar was sponsored by the College of American Pathologists (CAP). It s 1 year ago today that the World Health Organization declared COVID-19 a pandemic and basically set in stone a year that was going to change our lives probably forever, Richards said.
During that time, PCR testing became more of a household term, community and preoperative testing changed and expanded, and the FDA granted emergency use authorization for more at-home tests. Among them is the first molecular-based at-home test, which was authorized last week.